Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.80 | 19.06 |
| PEG Ratio (TTM) | -2.92 | 0.44 |
| P/S Ratio (TTM) | 2.24 | 3.39 |
| P/B Ratio (TTM) | 1.81 | 9.11 |
| P/FCF Ratio (TTM) | -13.96 | -35.46 |
| Price to 5YR AVG Earnings Ratio | 31.16 | 11.88 |
| Price to 5YR AVG FCF Ratio | -12.38 | -74.91 |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 21.97% | 5.51% |
| ROE (TTM) | 9.50% | 10.51% |
| Net Profit Margin (TTM) | 11.25% | 15.03% |
| ROIC 5YR AVG | 4.47% | 5.29% |
Growth (47%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1.32% | 27.46% | 21.92% |
| Revenue | 1.88% | -5.97% | -2.60% |
| Net Income | 0.04% | 51.09% | 39.65% |
| Cash Flow | -22.91% | -33.47% | 1,628.21% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.11 | 0.90 |
| Quick Ratio (TTM) | 0.92 | 0.70 |
| D/E Ratio (TTM) | 1.86 | 7.36 |
| Interest Coverage (TTM) | 4.24 | 4.86 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 1.79 | 1.57 |
| LTL to 5YR AVG FCF | -11.34 | -35.10 |
| Shares Outstanding Growth 5YR AVG | 7.14% | 11.41% |